C-Terminal Truncated α-Synuclein Fibrils Contain Strongly Twisted β-Sheets

C-terminal truncations of monomeric wild-type alpha-synuclein (henceforth WT-αS) have been shown to enhance the formation of amyloid aggregates both in vivo and in vitro and have been associated with accelerated progression of Parkinson’s disease (PD). The correlation with PD may not solely be a result of faster aggregation, but also of which fibril polymorphs are preferentially formed when the C-terminal residues are deleted. Considering that different polymorphs are known to result in distinct pathologies, it is important to understand how these truncations affect the organization of αS into fibrils. Here we present high-resolution microscopy and advanced vibrational spectroscopy studies that indicate that the C-terminal truncation variant of αS, lacking residues 109–140 (henceforth referred to as 1–108-αS), forms amyloid fibrils with a distinct structure and morphology. The 1–108-αS fibrils have a unique negative circular dichroism band at ∼230 nm, a feature that differs from the canonical ∼218 nm band usually observed for amyloid fibrils. We show evidence that 1–108-αS fibrils consist of strongly twisted β-sheets with an increased inter-β-sheet distance and a higher solvent exposure than WT-αS fibrils, which is also indicated by the pronounced differences in the 1D-IR (FTIR), 2D-IR, and vibrational circular dichroism spectra. As a result of their distinct β-sheet structure, 1–108-αS fibrils resist incorporation of WT-αS monomers.

[1]  Aloke K. Dutta,et al.  α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease. , 2017, Future medicinal chemistry.

[2]  John L. Robinson,et al.  Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease , 2017, Neuropathology and applied neurobiology.

[3]  D. Krainc,et al.  α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies , 2017, Nature Medicine.

[4]  Vinod Subramaniam,et al.  Evidence for Intramolecular Antiparallel Beta-Sheet Structure in Alpha-Synuclein Fibrils from a Combination of Two-Dimensional Infrared Spectroscopy and Atomic Force Microscopy , 2017, Scientific Reports.

[5]  R. Heeren,et al.  The Impact of N-terminal Acetylation of α-Synuclein on Phospholipid Membrane Binding and Fibril Structure* , 2016, The Journal of Biological Chemistry.

[6]  C. Sigurdson,et al.  Polymorphism of Amyloid Fibrils In Vivo. , 2016, Angewandte Chemie.

[7]  V. Subramaniam,et al.  Conformational Compatibility Is Essential for Heterologous Aggregation of α-Synuclein. , 2016, ACS chemical neuroscience.

[8]  T. Südhof,et al.  Propagation of prions causing synucleinopathies in cultured cells , 2015, Proceedings of the National Academy of Sciences.

[9]  D. Muller,et al.  Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death , 2015, Cell Death and Differentiation.

[10]  M. Giugliano,et al.  α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.

[11]  R. Tycko Amyloid Polymorphism: Structural Basis and Neurobiological Relevance , 2015, Neuron.

[12]  V. Subramaniam,et al.  Fibril breaking accelerates α-synuclein fibrillization. , 2015, The journal of physical chemistry. B.

[13]  V. Subramaniam,et al.  Solution conditions define morphological homogeneity of α-synuclein fibrils. , 2014, Biochimica et biophysica acta.

[14]  J. Grigoletto,et al.  Lysine residues at the first and second KTKEGV repeats mediate α-Synuclein binding to membrane phospholipids , 2014, Neurobiology of Disease.

[15]  E. Masliah,et al.  Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models , 2014, The Journal of Neuroscience.

[16]  Michele Vendruscolo,et al.  Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation , 2014, Proceedings of the National Academy of Sciences.

[17]  R. Mezzenga,et al.  ILQINS hexapeptide, identified in lysozyme left-handed helical ribbons and nanotubes, forms right-handed helical ribbons and crystals. , 2014, Journal of the American Chemical Society.

[18]  B. Meier,et al.  Unlike Twins: An NMR Comparison of Two α-Synuclein Polymorphs Featuring Different Toxicity , 2014, PloS one.

[19]  L. Sánchez,et al.  Inversion of supramolecular helicity in oligo-p-phenylene-based supramolecular polymers: influence of molecular atropisomerism. , 2014, Angewandte Chemie.

[20]  I. Lednev,et al.  Is Supramolecular Filament Chirality the Underlying Cause of Major Morphology Differences in Amyloid Fibrils? , 2014, Journal of the American Chemical Society.

[21]  R. Nolte,et al.  Beta sheets with a twist: the conformation of helical polyisocyanopeptides determined by using vibrational circular dichroism. , 2013, Chemistry.

[22]  M. Bonn,et al.  Determining in situ protein conformation and orientation from the amide-I sum-frequency generation spectrum: theory and experiment. , 2013, The journal of physical chemistry. A.

[23]  D. Eliezer The mysterious C-terminal tail of alpha-synuclein: nanobody's guess. , 2013, Journal of molecular biology.

[24]  B. Vestergaard,et al.  Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures , 2013, PloS one.

[25]  A. Ariza,et al.  Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration , 2013, Molecular Neurobiology.

[26]  P. Thomas,et al.  Alpha-synuclein truncation and disease , 2012 .

[27]  T. Keiderling,et al.  On the DMSO-dissolved state of insulin: a vibrational spectroscopic study of structural disorder. , 2012, The journal of physical chemistry. B.

[28]  Kenjiro Ono,et al.  Cross‐seeding effects of amyloid β‐protein and α‐synuclein , 2012, Journal of neurochemistry.

[29]  I. Lednev,et al.  Normal and reversed supramolecular chirality of insulin fibrils probed by vibrational circular dichroism at the protofilament level of fibril structure. , 2012, Biophysical journal.

[30]  B. Escuder,et al.  Vibrational Circular Dichroism Shows Reversible Helical Handedness Switching in Peptidomimetic l-Valine Fibrils. , 2012, The journal of physical chemistry letters.

[31]  Mathias Jucker,et al.  The Amyloid State of Proteins in Human Diseases , 2012, Cell.

[32]  L. Stefanis α-Synuclein in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[33]  Vladimir N Uversky,et al.  Α-synuclein misfolding and Parkinson's disease. , 2012, Biochimica et biophysica acta.

[34]  G. Muntané,et al.  α-synuclein phosphorylation and truncation are normal events in the adult human brain , 2012, Neuroscience.

[35]  P. Polavarapu,et al.  Isotope-assisted vibrational circular dichroism investigations of amyloid β peptide fragment, Aβ(16-22). , 2011, Journal of structural biology.

[36]  Martin T. Zanni,et al.  Concepts and Methods of 2D Infrared Spectroscopy , 2011 .

[37]  T. Joh,et al.  Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death* , 2011, The Journal of Biological Chemistry.

[38]  D. Shaw,et al.  pH dependence of the conformation of small peptides investigated with two-dimensional vibrational spectroscopy. , 2010, The journal of physical chemistry. B.

[39]  R. Nolte,et al.  Direct access to polyisocyanide screw sense using vibrational circular dichroism , 2010 .

[40]  Fabia Febbraro,et al.  Co‐expression of C‐terminal truncated alpha‐synuclein enhances full‐length alpha‐synuclein‐induced pathology , 2010, The European journal of neuroscience.

[41]  T. Measey,et al.  Self-aggregation of a polyalanine octamer promoted by its C-terminal tyrosine and probed by a strongly enhanced vibrational circular dichroism signal. , 2009, Journal of the American Chemical Society.

[42]  R. Hochstrasser,et al.  2D IR provides evidence for mobile water molecules in β-amyloid fibrils , 2009, Proceedings of the National Academy of Sciences.

[43]  E. Waxman,et al.  Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization. , 2009, Biochemistry.

[44]  L. V. van Vliet,et al.  DNA deformations near charged surfaces: electron and atomic force microscopy views. , 2009, Biophysical journal.

[45]  T. Jovin,et al.  A triple-emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type alpha-synuclein and its familial Parkinson's disease mutants. , 2009, Biochemistry.

[46]  J. Schulz,et al.  Accumulation and clearance of α‐synuclein aggregates demonstrated by time‐lapse imaging , 2008, Journal of neurochemistry.

[47]  A. Tokmakoff,et al.  Amide I two-dimensional infrared spectroscopy of proteins. , 2008, Accounts of chemical research.

[48]  I. Lednev,et al.  Vibrational circular dichroism shows unusual sensitivity to protein fibril formation and development in solution. , 2007, Journal of the American Chemical Society.

[49]  R. Purrello,et al.  Absorption flattening as one cause of distortion of circular dichroism spectra of Delta-RuPhen3 . H2TPPS complex. , 2007, Chirality.

[50]  D. D. Di Monte,et al.  Effect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation* , 2007, Journal of Biological Chemistry.

[51]  V. Subramaniam,et al.  Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from alpha-synuclein mutants. , 2006, Biophysical journal.

[52]  D. Marsh,et al.  Association of α-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR. , 2006 .

[53]  Y. Kawata,et al.  Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases. , 2005, The Journal of biological chemistry.

[54]  S. M. Park,et al.  Proteolytic Cleavage of Extracellular Secreted α-Synuclein via Matrix Metalloproteinases* , 2005, Journal of Biological Chemistry.

[55]  Olga Pletnikova,et al.  Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  V. Subramaniam,et al.  Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. , 2004, Biochemistry.

[57]  V. Subramaniam,et al.  NMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation , 2004, The EMBO journal.

[58]  S. Mukamel,et al.  Disentangling multidimensional femtosecond spectra of excitons by pulse shaping with coherent control. , 2004, The Journal of chemical physics.

[59]  Jonathan G. Lees,et al.  Analyses of circular dichroism spectra of membrane proteins , 2003, Protein science : a publication of the Protein Society.

[60]  A. Demchenko,et al.  Multiparametric probing of intermolecular interactions with fluorescent dye exhibiting excited state intramolecular proton transfer , 2003 .

[61]  Christopher A Ross,et al.  Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders , 2002, Neuron.

[62]  Sangram S. Sisodia,et al.  γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in? , 2002, Nature Reviews Neuroscience.

[63]  A. Brice,et al.  Alpha-synuclein and Parkinson's disease , 2000, Cellular and Molecular Life Sciences CMLS.

[64]  Jane M. Vanderkooi,et al.  Infrared Spectra of Amide Groups in α-Helical Proteins: Evidence for Hydrogen Bonding between Helices and Water , 2000 .

[65]  P. Lansbury,et al.  Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. , 2000, Biochemistry.

[66]  Y. Yang,et al.  Enhanced vulnerability to oxidative stress by α-synuclein mutations and C-terminal truncation , 2000, Neuroscience.

[67]  P. Lansbury,et al.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.

[68]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.

[69]  M. Illangasekare,et al.  Circular dichroism studies of distorted α-helices, twisted β-sheets, and β-turns , 1988 .

[70]  C. Chothia Coiling of β-pleated sheets , 1983 .

[71]  C. Chothia,et al.  Orthogonal packing of beta-pleated sheets in proteins. , 1982, Biochemistry.

[72]  T. Takagi,et al.  Novel transient circular dichroic spectra with a trough near 230 nm observed in the denaturation processes of lectins by sodium dodecyl sulfate. , 1981, Biochimica et biophysica acta.

[73]  N. Holzwarth,et al.  Infrared circular dichroism and linear dichroism of liquid crystals , 1973 .

[74]  Cyrus Chothia,et al.  Conformation of twisted β-pleated sheets in proteins , 1973 .

[75]  N. Holzwarth,et al.  Circular dichroism and rotatory dispersion near absorption bands of cholesteric liquid crystals , 1973 .

[76]  J. Schellman,et al.  The absorption spectra of simple amides and peptides. , 1967, The Journal of physical chemistry.

[77]  P. Polavarapu,et al.  Site-specific structure of Aβ(25-35) peptide: isotope-assisted vibrational circular dichroism study. , 2013, Biochimica et biophysica acta.

[78]  F. Salemme Structural properties of protein β-sheets , 1983 .

[79]  K. Kopple,et al.  Reverse Turns in Peptides and Protein , 1980 .

[80]  F. Salemme,et al.  Conformations of twisted parallel beta-sheets and the origin of chirality in protein structures. , 1979, Proceedings of the National Academy of Sciences of the United States of America.